Natural Killer Cell Activity and Interferon Production in Pancreatic Cancer Patients
Author Information
Author(s): K. Funab, B. Nilsson, G. Jacobsson, G.V. Alml
Primary Institution: University Hospital, Uppsala, Sweden
Hypothesis
Patients with pancreatic adenocarcinoma have deficiencies in the NK-IFN system.
Conclusion
Patients with pancreatic adenocarcinomas showed decreased natural killer cell activity and impaired interferon production.
Supporting Evidence
- Patients with pancreatic adenocarcinoma had significantly lower NK activity compared to healthy controls.
- Interferon production was diminished in patients when stimulated with Staphylococcus aureus Cowan I.
- Patients showed a decreased sensitivity of NK cells to interferon in vitro.
Takeaway
People with pancreatic cancer have weaker immune cells that don't work as well to fight the cancer.
Methodology
The study involved comparing peripheral blood leucocytes from pancreatic cancer patients and healthy controls using cytotoxicity assays and interferon production tests.
Participant Demographics
7 patients aged 53 to 76 years with pancreatic adenocarcinoma and 13 healthy controls aged 20 to 70 years.
Statistical Information
P-Value
0.024
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website